obesity drugs glp-1 news today With FDA approval of Wegovy pill, new era of oral weight loss begins A new study is raising

The company didnt use a GLP-1 Friendly label at first but added one to the packaging after customers reported that a label would help them identify products that met their dietary needs, according to Jennifer Barnes, vice president of brand marketing for Nestles frozen meals

These innovations not only expand therapeutic options but also address unmet needs in obesity and metabolic care, attracting wider clinical adoption

Incretin-based therapies and lifestyle interventions: the evolving role of registered dietitian nutritionists in obesity care

Wegovy remains covered for cardiovascular risk reduction and MASH liver disease under many plans